Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pyxis Oncology
Biotech
Pyxis whittles pipeline down to one clinical asset
Pyxis Oncology has axed one of two clinical candidates to streamline resources to its antibody-drug conjugate.
Gabrielle Masson
Dec 20, 2024 6:15am
Pyxis' shares fall on lukewarm early ADC results in solid tumors
Nov 21, 2024 2:30pm
FDA promotes Bumpus to replace Woodcock—Chutes & Ladders
Dec 1, 2023 9:48am
Hoping to pave a longer runway, Pyxis cuts staff, reprioritizes
Nov 8, 2023 5:00am
Apexigen accepts Pyxis' $16M bid 300 days after going public
May 24, 2023 9:20am
Biotechs face brutal pipeline decisions as M&A continues to lag
Aug 15, 2022 11:00am
